share_log
Reuters ·  Apr 25 06:16
Viking Therapeutics Shares Down 1.9% Premarket After Q1 Results
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment